Dan Frenkel,Adi Kopelevich,Veronica Lifshitz,Tali Benromano,Nofit Borenstein
申请号：
US13147406
公开号：
US08691760B2
申请日:
2010.02.02
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Use of an isolated peptide comprising an amino acid sequence being no more than 25 amino acids in length, the amino acid sequence comprising at least one aspartate or a homolog thereof, the peptide having an Insulin-Degrading Enzyme (IDE) inhibitory activity, for the manufacture of a medicament identified for treating a disease selected from the group consisting of diabetes, obesity, hyperglycemia, retinal damage, renal failure, nerve damage, microvascular damage and varicella-zoster virus (VZV) infection is disclosed.
